<p>Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS) are common and frequently lead to Aromatase Inhibitor (AI) discontinuation. Single nucleotide polymorphisms (SNPs) in candidate genes have been associated with AIMSS and AI discontinuation.  E1Z11 is a prospective cohort study designed to validate associations between 10 SNPs and AI discontinuation due to AIMSS. We enrolled postmenopausal</p>

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor    Musculoskeletal Symptoms (AIMSS)

Musculoskeletal System study with SNP Genotypes (Array) data on dbGaP (970 participants)

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

Description

Applying For Access

Summary